首页 > 市场调查报告书 > 製药

疫苗

市场调查报告书

商品编码

1706035

猪瘟疫苗市场：规模、份额、前景、按类型、分销管道和地区分類的机会分析（2025-2032 年）

Swine Fever Vaccine Market, by Type, by Vaccine Type, by Distribution Channel, and by Region Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032

出版日期: 2025年03月04日 | 出版商:

Coherent Market Insights | 英文 156 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2025 年全球猪瘟疫苗市场规模估计为 30.324 亿美元，预计到 2032 年将达到 45.898 亿美元，2025 年至 2032 年的复合年增长率为 6.1%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	30.324亿美元
效能数据	从2020年到2024年	预测期	2025年至2032年
预测期：2025-2032年复合年增长率：	6.10%	2032年价值预测	45.898亿美元

数字。 2025年猪瘟疫苗市场占有率（按地区）

猪瘟有两种类型：古典猪瘟（CSF）和非洲猪瘟（ASF）。猪瘟（CSF）是一种高度传染性的猪病毒性疾病。疾病的严重程度取决于病毒的病毒株、猪群的免疫状态和猪的年龄。另一方面，非洲猪瘟是一种高度传染性和致命性的病毒性疾病，会影响所有年龄层的家猪和野猪。急性非洲猪瘟和脑脊髓炎都会导致高死亡率，最严重的病例死亡率接近 100%。这两种疾病也可以发展为较温和的形式，死亡率较低。猪群死亡数量突然增加可能是猪瘟的征兆。 ASF 和 CSF 急性期的临床症状包括忧郁、发烧、食慾不振以及耳朵、鼻子和四肢出现红色、紫色或蓝色斑点。随着病情的进展，可能会出现呕吐和腹泻（非洲猪瘟时为血性腹泻），同时伴随呼吸困难和咳嗽。这些疾病透过与受感染的猪隻直接接触或接触受污染的猪圈、卡车或衣物传播。对于这两种疾病，猪可以长期携带病毒，因此在疫情爆发期间必须限制猪的活动。

市场动态

政府机构加强防止猪瘟蔓延，并透过组织宣传宣传活动提高人们的意识，预计将在预测期内推动市场成长。例如，2022年6月，美国农业部（USDA）动植物卫生检验局（APHIS）宣布了新的倡议，以防止非洲猪瘟在美国的传入和传播。透过名为「保护我们的猪」的推广和宣传宣传活动，动植物卫生检验局将向商业猪肉生产商、兽医和养猪户提供资讯和资源，以保护美国生猪数量和猪肉产业。

本研究的主要特点

本报告对全球猪瘟疫苗市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模。
它揭示了各个领域的潜在商机，并解释了该市场的有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
它根据公司亮点、产品系列、关键亮点、财务表现和策略等参数，介绍了全球猪瘟疫苗市场的主要企业概况。
本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
本研究报告针对该产业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
相关人员将透过用于分析全球猪瘟疫苗市场的各种策略矩阵来做出决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 3,032.4 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	6.10%	2032 Value Projection:	USD 4,589.8 Mn

There are two types of swine fever - Classical Swine Fever (CSF) and African Swine Fever (ASF). Classical swine fever (CSF) is an extremely contagious viral disease in pigs. The severity of the disease varies with the strain of the virus, the immune status of the herd, and the age of the pig. African swine fever, on the other hand, is a highly contagious and deadly viral disease affecting both domestic and feral swine of all ages. Acute forms of both ASF and CSF can cause high death rates, with mortality approaching 100% in the most severe form of ASF. Both diseases may also occur in milder forms with lower mortality rates. Swine fever could be considered a possibility in case of a sudden increase in deaths in a group of pigs. Clinical signs of acute forms of both ASF and CSF include depression, fever, loss of appetite, and red, purple, or blue blotching of the ears, nose, and limbs. Vomiting and diarrhea (bloody diarrhea for ASF) may occur as the disease progresses, along with breathing difficulties and coughing. The diseases spread through direct contact with infected pigs or contact with contaminated pens, trucks, or clothing. In both diseases, pigs can remain carriers of the disease for long period and therefore moving pigs during an outbreak must be restricted.

Market Dynamics

Increasing efforts by the government bodies to create awareness and prevent the spread of swine fever by organizing awareness campaigns are expected to drive the market growth over the forecast period. For instance, in June 2022, the United States Department of Agriculture's (USDA) Animal and Plant Health Inspection Service (APHIS) announced new efforts to help prevent the introduction and spread of African swine fever in the U.S. Through an outreach and awareness campaign called "Protect Our Pigs," APHIS will support commercial pork producers, veterinarians, and pig owners with information and resources to help safeguard America's swine population and the pork industry.

Key features of the study:

This report provides an in-depth analysis of the global swine fever vaccine market, market size (US$ Million), and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global swine fever vaccine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Merck & Co., Inc. (Merck Animal Health), Ceva, Zoetis Services LLC, Boehringer Ingelheim International GmbH, Indian Immunologicals Ltd., Bioveta, a.s., Komipharm, and EC21 Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global swine fever vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global swine fever vaccine market

Detailed Segmentation:

Global Swine Fever Vaccine Market, By Type:
- African Swine Fever
- Classical Swine Fever
Global Swine Fever Vaccine Market, By Vaccine Type:
- Live-Attenuated
- Chimeric (Live-attenuated or inactivated)
- Subunit or vector system based
- Replicon vaccine
Global Swine Fever Vaccine Market, By Distribution Channel:
- Public
- Private
Global Swine Fever Vaccine Market, By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles
- Merck & Co., Inc. (Merck Animal Health)
- Ceva
- Zoetis Services LLC
- Boehringer Ingelheim International GmbH
- Indian Immunologicals Ltd.
- Bioveta, a.s.
- Komipharm
- EC21 Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Vaccine Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Epidemiology
Regulatory Scenario
PEST Analysis
New Product Approval/Launch

4. Global Swine Fever Vaccine Market - Impact of Coronavirus (COVID-19) Pandemic

Economic Impact
COVID-19 Epidemiology
Demand and Supply Analysis

5. Global Swine Fever Vaccine Market, By Type, 2020 - 2032, (US$ Million)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
African Swine Fever
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Classical Swine Fever
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)

6. Global Swine Fever Vaccine Market, By Vaccine Type, 2020 - 2032, (US$ Million)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Live-Attenuated
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Chimeric (Live-attenuated or inactivated)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Subunit or vector system based
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Replicon vaccine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)

7. Global Swine Fever Vaccine Market, By Distribution Channel, 2020 - 2032, (US$ Million)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Public
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Private
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)

8. Global Swine Fever Vaccine Market, By Region, 2020 - 2032, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, By Region, 2021-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Million)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Million)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Million)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Million)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Million)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (US$ Million)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Merck & Co., Inc. (Merck Animal Health)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Ceva
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Zoetis Services LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Boehringer Ingelheim International GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Indian Immunologicals Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Bioveta, a.s.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Komipharm
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
EC21 Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies

10. Analyst Recommendation

Wheel of Fortune
Analyst View
Coherent Opportunity Map

11. Section

References
Research Methodology
About Us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

猪瘟疫苗市场：规模、份额、前景、按类型、分销管道和地区分類的机会分析（2025-2032 年）